Literature DB >> 28454331

Centrosome amplification in chondrosarcomas: A primary cell culture and cryopreserved tumor sample study.

Carla Aparecida Pinheiro1,2, Iberê Cauduro Soares1,3, Valter Penna4, Jeremy Squire5, Rui Manuel Vieira Reis1,6, Sandra Regina Morini da Silva1, Isabela de Carvalho1, Marjori Leiva Camparoto1, Maicon Fernando Zanon da Silva1, Adhemar Longatto Longatto Filho6,7,8,9.   

Abstract

The genetics background underlying the aggressiveness of chondrosarcoma (CS) is poorly understood. One possible cause of malignant transformation is chromosomal instability, which involves an error in mitotic segregation due to numerical and/or functional abnormalities of centrosomes. The present study aimed to evaluate centrosome amplification in cryopreserved samples of tumor tissue from patients with CS. An analysis was performed on 3 primary cultures of tumors from patients who underwent surgery between January 2012 and December 2012 at the Department of Orthopedics at the Barretos Cancer Hospital (Barretos, Brazil). Additionally, cryopreserved tumor specimens were analyzed from 10 patients. The data were assessed using immunocytochemistry and immunohistochemistry staining techniques with monoclonal antibody anti-γ-tubulin. A total of 4 samples of CS cultured cells were obtained from 3 patients. A recurrence of a histological grade III tumor was detected in a female patient with Ollier's syndrome. The other 2 cases were grade I and III. The incidence of centrosome amplification in the primary cultures ranged from 15-64% of the cells. Whereas control cultured fibroblasts showed baseline levels of 4% amplified cells. For the cryopreserved specimens, two independent observers analyzed each sample and counted the cells stained with γ-tubulin, verifying the percentage of affected cells to be a mean of 14%, with the number of clusters ranging between 0-6 per slide. In conclusion, centrosome amplification was found to be a consistent biological feature of CS and may underlie chromosomal instability in this tumor.

Entities:  

Keywords:  centrosome amplification; chondrosarcoma; primary cell culture

Year:  2017        PMID: 28454331      PMCID: PMC5403437          DOI: 10.3892/ol.2017.5633

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

Review 1.  Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects.

Authors:  Kenji Fukasawa
Journal:  Horm Cancer       Date:  2011-04       Impact factor: 3.869

2.  New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.

Authors:  David Monderer; Alexandrine Luseau; Amélie Bellec; Emmanuelle David; Stéphanie Ponsolle; Soraya Saiagh; Sylvain Bercegeay; Philippe Piloquet; Marc G Denis; Laurence Lodé; Françoise Rédini; Marine Biger; Dominique Heymann; Marie-Françoise Heymann; Ronan Le Bot; François Gouin; Frédéric Blanchard
Journal:  Lab Invest       Date:  2013-08-19       Impact factor: 5.662

3.  Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.

Authors:  Yoshiaki Yamamoto; Taku Misumi; Satoshi Eguchi; Yasuyo Chochi; Seiji Kitahara; Motonao Nakao; Kazuhiro Nagao; Takahiko Hara; Shigeru Sakano; Tomoko Furuya; Atsunori Oga; Shigeto Kawauchi; Kohsuke Sasaki; Hideyasu Matsuyama
Journal:  Hum Pathol       Date:  2011-06-17       Impact factor: 3.466

4.  Results of hyperamplification of centrosomes in naturally developing tumors of dogs.

Authors:  A Setoguchi; M Okuda; E Nishida; M Yazawa; T Ishizaka; S H Hong; M Hisasue; R Nishimura; N Sasaki; Y Yoshikawa; K Masuda; K Ohno; H Tsujimoto
Journal:  Am J Vet Res       Date:  2001-07       Impact factor: 1.156

5.  Chromosomal instability in osteosarcoma and its association with centrosome abnormalities.

Authors:  K Al-Romaih; J Bayani; J Vorobyova; J Karaskova; P C Park; M Zielenska; J A Squire
Journal:  Cancer Genet Cytogenet       Date:  2003-07-15

6.  Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability.

Authors:  Linda Moskovszky; Katalin Dezsö; Nick Athanasou; Miklós Szendröi; László Kopper; Karolina Kliskey; Piero Picci; Zoltán Sápi
Journal:  Mod Pathol       Date:  2010-01-08       Impact factor: 7.842

Review 7.  Update on chondrosarcomas.

Authors:  Warren A Chow
Journal:  Curr Opin Oncol       Date:  2007-07       Impact factor: 3.645

8.  Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.

Authors:  Anne C Onishi; Alexander M Hincker; Francis Y Lee
Journal:  Sarcoma       Date:  2010-12-30

9.  Chondrosarcoma: with updates on molecular genetics.

Authors:  Mi-Jung Kim; Kyung-Ja Cho; Alberto G Ayala; Jae Y Ro
Journal:  Sarcoma       Date:  2011-02-15

Review 10.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

View more
  1 in total

Review 1.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.